Emicizumab (Anti-F9 / Factor IX)

Emicizumab (Anti-F9 / Factor IX) is a bispecific monoclonal antibody that bridges activated factor IX and factor X to replace the function of missing activated factor VIII, thereby restoring hemostasis. Emicizumab can be used for hemophilia A research. MW: 145.5 KD.

• Supplier: Selleck Chemicals
• Product #: A2502
• Sku #: A2502-1mg